AC
Insider
Ashley Cordova
Chief Executive OfficerAshley Cordova (Chief Executive Officer) filed 3 Form 4 reports in the past 24 months (1 purchase, 2 sales), most often in NVCR. Across 1 priced purchase filing, the average 21-session return was +21.5% from execution and +6.2% from disclosure (delay-adjusted; derived). The largest single filing was $997K of NVCR (81,550 sh × $12.22, as filed), executed Sep 5 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+21.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+6.2%
same 1 filings, from disclosure
Filings, ttm
3
1 buys · 2 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Sep 5 2025
Filed Sep 8 2025
Volume by month
Buys $997K
Sells $372K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
3 filings
Sector per market data · by filing · past 24 months
Most traded names
NVCR
NVCR
NVCR · 1 buy · 2 sells
3 filings
Recent filings
NVCRPURCHASE
NovoCure Ltd
View filing →
$997K81,550 sh × $12.22
Exec Sep 5 2025
Filed Sep 8 2025 · 7:10 AM ET NVCRSALE NovoCure Ltd View filing → $186K
9,345 sh × $19.92
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET NVCRSALE NovoCure Ltd View filing → $186K
9,345 sh × $19.92
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET